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Robot assisted radical prostatectomy (RARP) is one of the most common treatments for
prostate cancer in the United States. The adoption of this procedure has been very rapid.
The first reported procedure was in 2000
1 however in 2007 more than 60% of all radical
prostatectomy cases were robotically assisted (Intuitive Surgical data, Sunnyvale, CA,
USA). The focus of this paper will examine the reported outcomes of this technology
including our centers’ experience. Future directions will also be explored.
The first reported radical prostatectomy was performed by Hugh Hampton Young in 1904
via a perineal approach.
2 The retropubic approach was first performed by Terrence Millen
in 1947.
3 However, the morbidity of these operations caused both patient and surgeon alike
to avoid this curative treatment. External beam radiation provided a viable alternative
albeit a less efficacious one with its own set of morbidities.
Patrick Walsh’s revolutionary contributions in defining the anatomy of the prostate and
its surrounding structures began to turn the tide.
4 No longer was the treatment more
harmful than the disease. Patients could undergo radical prostatectomy and have an
excellent chance of regaining continence and potency postoperatively. Over the years since
Dr. Walsh’s seminal work, many centers have developed expertise with open radical
prostatectomy. The operation including the concepts of suturing the dorsal venous
complex and nerve sparing had become the mainstay of treatment for men with organ
confined prostate cancer. 
However, the advent of large organ ablative urological surgery was dawning in the early
1990’s heralded by Dr. Ralph Clayman’s report of the first laparoscopic nephrectomy.
5
Later careful examination demonstrated the benefits of the laparoscopic nephrectomy with
less pain, less blood loss, quicker return to work and shorter hospital stay.
6 Dunn and
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scopic radical nephrectomy cases. The cohort was compared to
an open counterpart of radical nephrectomy. Blood loss was cut
from 451 cc to 172 cc. Hospital stay was 3.4 versus 5.2 days.
Pain medication requirement and time to normal activities were
much improved. Most importantly however, cancer recurrence
rates were identical. Oncological soundness has been demon-
strated in this and other large studies.
7
Laparoscopic radical prostatectomy was later explored by
Clayman and Schussler.
8 However they concluded from their
series of 9 laparoscopic cases that the procedures were too
difficult with very long operative times with a mean of 9.4
hours. Of the 9 patients, 1 had a positive margin and 6 were
continent. However, there were significant complications
consisting of cholecystitis, thrombophlebitis, and a small bowel
port site hernia. Thus, they concluded that the potential benefits
of a minimally invasive procedure are lost since the morbidity of
the open surgical wound is well tolerated.
However, further improvement in laparoscopic skills and
refinement of techniques allowed Guillonneau to report on the
Montsouris experience in 2000.
9 The results of their technique
were very encouraging. The average OR time was 3 hours.
Estimated blood loss was 250 cc. The conversion rate was zero.
Patients were typically discharged to home on day 3 or 4
without a Foley catheter. Thus, the race began to reproduce the
results of this series. However, Kavoussi published an editorial
questioning the wisdom of tackling prostatectomy with a
laparoscopic approach until the procedure became better
established by centers of excellence.
10 While reports suggested
early continence and improved convalescence for the laparo-
scopic approach, data regarding cancer control in regard to
margins and prostate-specific antigen (PSA) recurrence was
still immature.
The advent of robot assisted radical prostatectomy
One center attempting to reproduce the results of Guillonneau
reported on their frustration and subsequent solution. Menon
and colleagues reported on their first difficult steps of laparo-
scopic prostatectomy. They added the daVinci Surgical System
(Intuitive Surgical, Sunnyvale, CA, USA) and their outcomes
began to improve.
11 Their initial report focused on 48 standard
laparoscopic prostatectomies and 50 robotic assisted cases in a
12-month period. Preoperative characteristics were identical.
Most of the postoperative outcomes were very close, however,
even in this early series, robotic cases had a lower mean estima-
ted blood loss. Also of note, the operative (OR) case time trend
seemed to continue to improve using the robotic technique
while time improvement seemed to have plateaued with the
standard laparoscopic approach.
The benefits the robotic surgical system are well touted.
Wristed instrumentation, tremor filtration, three dimensional
vision and an ergonomic surgeon console clearly benefit
surgeons with minimal laparoscopic experience to quickly feel
comfortable with even complex laparoscopic reconstructive
tasks.
Menon followed this initial report with other maturing data
from their series. In a report of their initial 1,100 cases, Menon
compared his mature series of open radical prostatectomy to his
large experience of the new robotic technique.
12 They found
that their OR was actually faster with the robot. Blood loss was
markedly improved as were complication rates, catheter time,
hospital stay, postoperative pain score and times to continence
and potency.
12
Menon’s group most recently reported their series of over
2,700 patients. Their now very mature series demonstrates
excellent functional outcomes with 93% of men wearing 1 pad
or less per day and 79.2% of men who underwent bilateral
nerve sparing were able to have successful sexual intercourse
by defined as a positive response to question 2 of the Sexual
Health Inventory for Men (SHIM) questionnaire. Perioperative
data remained consistent with a mean estimated blood loss
(EBL) of 100 cc, 96% day 1 discharge rate, and mean OR time
of 154 minutes. Most importantly, however, the 5 year actuarial
biochemical free survival was 84%.
13
Spurred by Menon’s initial work, Perer et al.
14 reported on a
their initial experience with robotic prostatectomy. In another
article, Ahlering demonstrated excellent proficiency over his
learning curve for a surgeon who was laparoscopically naïve.
The time to 4-hour proficiency was 12 cases. Mean blood loss
was 145 cc. Early continence was excellent with zero pad
continence being gained by 81% of patients at 3 months. The
mean positive margin rate was 35.5% however this number has
dropped substantially in the University of California (UCI)
experience. Using a distinct technique change of using a stapler
to divide the dorsal venous complex, the pT2 margin rates
dropped to 4.7%.
15
Smith has also shown an experienced open radical prostat-
ectomist can be successful with a robotic approach. Although in
early reports of their work they did not see a difference in
length of hospital stay
16 or transfusion
17 rate, Smith et al. did note
a significantly lower positive margin rate with use of the robotic
approach than with their very large open radical prostatectomy
experience at Vanderbilt. They examined the last 200 cases of
open against their last 200 robot prostatectomy cases.
18 Altho-
ugh there was a trend toward higher percentage of tumor to
gland involvement in the open cases, the margin rate was lower
(15% to 35%) for robotic prostatectomy. For pT2 margins, the
difference was striking; 9.4% with the robot versus 24.1% for
the open procedure. The location of the positive margins was
not different with the apex being the most common area for
both approaches.
The penn experience
The author’s own experience of robot prostatectomy at the
University of Pennsylvania has now reached over 1,300 cases
to the date of this writing. My personal experience is now over
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OR time is 120 minutes. We prefer a transperitoneal 6 port
approach. The bladder is dropped initially and the dorsal
venous complex is divided with a stapler (Fig. 1). The bladder
is divided from the prostate and the seminal vesicles are
approached anteriorly. The rectum is thoroughly dropped away
from the posterior surface of the prostate and the pedicles are
controlled with clips (Fig. 2). A running anastomosis is
employed for the vesicourethral anastomosis (Fig. 3). We do
not routinely leave Jackson Pratt (JP) drains.
Patients are discharged on postoperative day #1 96% of the
time. Patients are encouraged to ambulate the first night of the
operation. Diet is held at clear for the first day and then
advanced to a regular diet in the AM. Pain medication consists
of toradol around the clock with additional narcotic available on
a prn basis.
Foley catheters are removed on postoperative day 6 or 7
without cystograms. Patients typically return to work in 2 to 3
weeks and are allowed to assume unrestricted activity by 3
weeks.
The major complications rate has been less than 2%
consisting of transfusions (10), rectal injury (5), Veress needle
injury (1), symptomatic lymphocele requiring drain placement
(8), prolonged urine leak requiring drain placement (3), and
bladder neck contracture (5). One of these bladder neck
contractures has required an open repair. 
In regard to continence requiring zero pads or a security pad,
approximately 20% of patients are continent on catheter
removal, 50% by one month and 80% by 3 months. Patients
with a preoperative SHIM of 22 or more and aged 55 or less
have been able to have successful intercourse with the help of
phosphodiesterase5 (PDE5) inhibitors at a rate of 80% by 18
months postoperatively.
Our margin rates have steadily been improving. Early in our
experience within the first 200 cases, the overall margin rate was
20% with a pT2 margin rate of 10%. However, with consistent
communication with our genito urinary (GU) pathologists and
technical modifications consisting of an interfascial nerve
sparing technique, early retrograde release of the neurovascular
bundles and continued use of a stapler for division of the dorsal
venous complex, our margin rates for the last 500 cases has been
11% with a pT2 margin rate 4.5% and pT3 margin rate of 35%. 
Robotic prostatectomy has improved the open approach
However, likely the most important factor for success with
radical prostatectomy is not so much approach but rather
surgeon experience. Scardino has shown the surgeon experi-
ence is an independent predictor for success during radical
prostatectomy. Eastham et al.
19 reported lower positive margins
rates are encountered by more experienced surgeons during
open radical prostatectomy. When 26 surgeons were examined
and patient characteristics such as PSA level, extracapsular
extension, Gleason score, surgery date and surgical volume
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Fig. 1.Photograph of laparoscopic stapler placed across the dorsal venous complex.
Fig. 2. The right neurovascular bundle is being dissected away from the prostate in
an interfascial technique.
Fig. 3. View of the apposition of the bladder to the urethra during vanVelthoven
anastomosis.were controlled for, surgeon volume was a clear independent
risk factor for a positive surgical margin. Furthermore, PSA
recurrence in a similar study by Klein revealed a similar result.
20
As such, as the robotic prostatectomy surgical experience
broadens, the outcomes should continue to improve.
However, the robotic and laparoscopic approaches have
brought innovation to radical prostatectomy. The vanVelthoven
anastomosis was made possible by a laparoscopic approach; the
technique involves the creation of the urethrovesical anasto-
mosis by a double armed suture that is initiated at the 6 o’clock
position and run continuously to the 12 o’clock position with a
single knot at the top.
21 This technique has proved reliable, rapid
with a minimum of complications such as urine leak or bladder
neck contractures.
Menon has reported the Veil of Aphrodite technique of nerve
sparing where the prostatic fascia is incised very anteriorly. The
goal of the approach is to spare anterior accessory nerves that
may be important for potency. Improved potency was indeed
demonstrated for men with normal preoperative potency in a
small study comparing these patients to a historical control of
standard nerve sparing.
22 However, the controversy surrounded
this technique despite the positive outcomes due to a concern of
closer margins. However, these data led to a comparative study
by Walsh where he examined a high anterior fascia release
(HAR) to his standard technique of nerve sparing. He noted
clearly improved outcomes where HAR patients had a higher
chance of regaining a SHIM score of 16 (93% to 77%). He also
did not see an increase in the positive margin rates but theorized
that the success of this technique was not improved number of
nerves spared but decreased traction on the neurovascular
bundle during dissection. 
Future directions
Attempts to further decrease morbidity and increases in
computing power and technological innovations will continue
to drive progress in robotics and computer assisted surgery. The
development of single port surgery is a clear fit with robotic
technology. Gettman
23 reported transvaginal laparoscopic
nephrectomy in the porcine model where a single 5 mm tran-
sabdominal port was used in conjunction with a multiple ports
placed through the vagina. Successful nephrectomy was
performed in 5 out of 6 animals. The relatively rudimentary
devices used in this report have been improved with develop-
ment of articulating instruments and single site access ports that
allow multiple instrument passage. Kaouk
24 has reported on
laparoscopic single port prostatectomy in 4 patients.Mean OR
time was 285 minutes and EBL was 288 cc. No intraoperative
complications occurred. One patient did develop a rectourethral
fistula. Refinement of robotic tools will allow further explora-
tion and refinement of this challenging technique.
Other scientific breakthroughs will lead to the ability to ‘see’
structures that cannot be seen with the naked eye. Boyette et
al.
25 has reported on optical real time imaging of cavernous
nerves with confocal microscopy. This technique was initiated
with the creation of a fluorescent nerve tracer. This tracer was
injected into the penis of a group of rats. In vivo imaging during
laparoscopy using a fiber wand attached to a confocal micro-
scope was able to visualize these nerves in the pelvis. In the
future, it may be possible to label specific structures that can
literally ‘light up’ during a robotic approach. This could enable
sparing of certain structures such as nerves and definitive
removal of other cancerous tissues. 
The robotic prostatectomy has indeed become the most common
extirpative operation performed for prostate cancer in the
United States. However, the development and refinement of
this procedure has led to improved outcomes for patients under-
going either robotic or open radical prostatectomy. Future
improvements are inevitable and soon our imagination will be
our only limit to the progress of surgery.
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